Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

Author： Youdim M. B. H.   Fridkin M.   Zheng H.  

Publisher： Springer Publishing Company

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.111, Iss.10-11, 2004-10, pp. : 1455-1471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Parkinson’s and Alzheimer’s diseases: Protein aggregations and neuroprotection

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 333-336

Humana Press, Inc

Access to resources Recommend Favorite

Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease

By Van der Schyf Cornelis J   Geldenhuys Werner J   Youdim Moussa BH  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 411-423

Future Medicine

Access to resources Recommend Favorite

Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

By Li Chao   Guo Yuan   Xie Wenjie   Li Xingang   Janokovic Joseph   Le Weidong  

Neurochemical Research, Vol. 35, Iss. 10, 2010-10 ,pp. : 1546-1556

Springer Publishing Company

Access to resources Recommend Favorite

VPS41-mediated neuroprotection in a Caenorhabditis elegans model of Parkinson’s disease

By Tyson Trevor   Brundin Patrik  

Future Neurology, Vol. 7, Iss. 3, 2012-05 ,pp. : 255-258

Future Medicine

Access to resources Recommend Favorite

Prevalence of Parkinson’s disease and other types of Parkinsonism

By Bergareche A.   Puente E.   López deMunain A.   Sarasqueta C.   Arce A.   Poza J.   Martí-Massó J.  

Journal of Neurology, Vol. 251, Iss. 3, 2004-03 ,pp. : 340-345

Springer Publishing Company

Access to resources Recommend Favorite